Return to homepagePandemic Pact

COVID-19 Therapeutics I: Drug combination for therapeutic induction of T cells against COVID-19 (IndTCOVID-19) - Conducting clinical study and immune monitoring

  • Funded by Federal Ministry of Research, Technology and Space (BMFTR)
  • Total publications:0 publications

Grant number: 03LW0005

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2021
    2023

  • Known Financial Commitments (USD)

    $1,237,004.44

  • Funder

    Federal Ministry of Research, Technology and Space (BMFTR)

  • Principal Investigator

    N/A

  • Research Location

    Germany

  • Lead Research Institution

    Eberhard Karls Universität Tübingen

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Immunity

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Unspecified

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

N/A